GCAN 0.00 The Greater Cannabis Company, Inc.
| Range: | 4.0E-4-0.0015 | Vol Avg: | 1584921 | Last Div: | 0 | Changes: | 0 |
| Beta: | 1.62 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Sep 18 2018 | Empoloyees: | 1 | ||
| CUSIP: | 391657103 | CIK: | 0001695473 | ISIN: | US3916571033 | Country: | US |
| CEO: | Mr. Aitan Zacharin | Website: | https://www.gcanrx.com | ||||
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company was founded in 2014 and is based in Baltimore, Maryland.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow